Determining whether curcumin degradation/condensation is actually bioactivation (Review)

Jankun,Jerzy; Wyganowska-Świątkowska,Marzena; Dettlaff,Katarzyna; Jelińska,Anna; Surdacka,Anna; Wątróbska-Świetlikowska,Dorota; Skrzypczak-Jankun,Ewa

doi:10.3892/ijmm.2016.2524

Determining whether curcumin degradation/condensation is actually bioactivation (Review)

Authors:
- Jerzy Jankun
- Marzena Wyganowska-Świątkowska
- Katarzyna Dettlaff
- Anna Jelińska
- Anna Surdacka
- Dorota Wątróbska-Świetlikowska
- Ewa Skrzypczak-Jankun
View Affiliations

Affiliations: Urology Research Center, Department of Urology, College of Medicine, University of Toledo, Toledo, OH 43614, USA, Department of Conservative Dentistry and Periodontology, Poznań University of Medical Sciences, 60-812 Poznan, Poland, Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Ponań, Poland, Department of Pharmaceutical Technology, Medical University of Gdansk, 80-416 Gdansk, Poland
Published online on: March 11, 2016 https://doi.org/10.3892/ijmm.2016.2524
Pages: 1151-1158

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin has been shown to exert therapeutic or protective effects against a variety of diseases, such as cancer, pulmonary diseases, neurological, liver, metabolic, autoimmune, cardiovascular diseases and numerous other chronic ailments. Over 116 clinical studies on curcumin in humans were registered with the US National Institutes of Health in 2015. However, it is mystifying how curcumin can be so effective in the treatment of many diseases since it has very low water solubility and bioavailability. Furthermore, curcumin is not stable under various conditions; its degradation or condensation into different bioactive compounds may be responsible for its biological activities rather than curcumin itself. In this review, we provide evidence of curcumin degradation and condensation into different compounds which have or may have health benefits themselves. Literature reviews strongly suggest that these molecules contribute to the observed health benefits, rather than curcumin itself.

View Figures

View References

1	Manolova Y, Deneva V, Antonov L, Drakalska E, Momekova D and Lambov N: The effect of the water on the curcumin tautomerism: A quantitative approach. Spectrochim Acta A Mol Biomol Spectrosc. 132:815–820. 2014. View Article : Google Scholar : PubMed/NCBI
2	Fu S, Shen Z, Ajlouni S, Ng K, Sanguansri L and Augustin MA: Interactions of buttermilk with curcuminoids. Food Chem. 149:47–53. 2014. View Article : Google Scholar
3	Gostner J, Ciardi C, Becker K, Fuchs D and Sucher R: Immunoregulatory impact of food antioxidants. Curr Pharm Des. 20:840–849. 2014. View Article : Google Scholar
4	Gupta SC, Kismali G and Aggarwal BB: Curcumin, a component of turmeric: From farm to pharmacy. Biofactors. 39:2–13. 2013. View Article : Google Scholar : PubMed/NCBI
5	Maruta H: Herbal therapeutics that block the oncogenic kinase PAK1: A practical approach towards PAK1-dependent diseases and longevity. Phytother Res. 28:656–672. 2014. View Article : Google Scholar
6	Srinivasan K: Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr. 54:352–372. 2014. View Article : Google Scholar
7	Current clinical trials on curcumin. US National Institutes of Health, Clinical Trial Registry; June. 2015. 2015
8	Bar-Sela G, Epelbaum R and Schaffer M: Curcumin as an anticancer agent: Review of the gap between basic and clinical applications. Curr Med Chem. 17:190–197. 2010. View Article : Google Scholar
9	Chainani-Wu N: Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med. 9:161–168. 2003. View Article : Google Scholar : PubMed/NCBI
10	Goel A, Kunnumakkara AB and Aggarwal BB: Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol. 75:787–809. 2008. View Article : Google Scholar
11	Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock R: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 14:4491–4499. 2008. View Article : Google Scholar : PubMed/NCBI
12	Shen L and Ji HF: Contribution of degradation products to the anticancer activity of curcumin. Clin Cancer Res. 15:7108author reply 7108–7109. 2009. View Article : Google Scholar : PubMed/NCBI
13	Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY and Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 15:1867–1876. 1997. View Article : Google Scholar : PubMed/NCBI
14	Tønnesen HH: Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie. 57:820–824. 2002.
15	Schneider C, Gordon ON, Edwards RL and Luis PB: Degradation of Curcumin: From Mechanism to Biological Implications. J Agric Food Chem. 63:7606–7614. 2015. View Article : Google Scholar : PubMed/NCBI
16	Metzler M, Pfeiffer E, Schulz SI and Dempe JS: Curcumin uptake and metabolism. Biofactors. 39:14–20. 2013. View Article : Google Scholar
17	Mohanty C and Sahoo SK: The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 31:6597–6611. 2010. View Article : Google Scholar : PubMed/NCBI
18	Tønnesen HH and Karlsen J: Studies on curcumin and curcuminoids. VI Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch. 180:402–404. 1985. View Article : Google Scholar
19	Priyadarsini KI: The chemistry of curcumin: From extraction to therapeutic agent. Molecules. 19:20091–20112. 2014. View Article : Google Scholar : PubMed/NCBI
20	Agrawal DK and Mishra PK: Curcumin and its analogues: Potential anticancer agents. Med Res Rev. 30:818–860. 2010.
21	Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E and Pommier Y: Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem. 40:3057–3063. 1997. View Article : Google Scholar : PubMed/NCBI
22	Jayaprakasam B, Vanisree M, Zhang Y, Dewitt DL and Nair MG: Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J Agric Food Chem. 54:5375–5381. 2006. View Article : Google Scholar : PubMed/NCBI
23	Jung KJ, Go EK, Kim JY, Yu BP and Chung HY: Suppression of age-related renal changes in NF-kappaB and its target gene expression by dietary ferulate. J Nutr Biochem. 20:378–388. 2009. View Article : Google Scholar
24	Murakami Y, Hirata A, Ito S, Shoji M, Tanaka S, Yasui T, Machino M and Fujisawa S: Re-evaluation of cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res. 27:801–807. 2007.PubMed/NCBI
25	Chang YC, Lee FW, Chen CS, Huang ST, Tsai SH, Huang SH and Lin CM: Structure-activity relationship of C6-C3 phenylpropanoids on xanthine oxidase-inhibiting and free radical-scavenging activities. Free Radic Biol Med. 43:1541–1551. 2007. View Article : Google Scholar : PubMed/NCBI
26	Shen L and Ji HF: Insights into the inhibition of xanthine oxidase by curcumin. Bioorg Med Chem Lett. 19:5990–5993. 2009. View Article : Google Scholar : PubMed/NCBI
27	Gordon ON and Schneider C: Vanillin and ferulic acid: Not the major degradation products of curcumin. Trends Mol Med. 18:361–363; author reply 363–364. 2012. View Article : Google Scholar : PubMed/NCBI
28	Gordon ON, Luis PB, Ashley RE, Osheroff N and Schneider C: Oxidative transformation of demethoxy- and bisdemethoxycurcumin: Products, mechanism of formation, and poisoning of human topoisomerase IIα. Chem Res Toxicol. 28:989–996. 2015. View Article : Google Scholar : PubMed/NCBI
29	Griesser M, Pistis V, Suzuki T, Tejera N, Pratt DA and Schneider C: Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem. 286:1114–1124. 2011. View Article : Google Scholar :
30	Ketron AC, Gordon ON, Schneider C and Osheroff N: Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry. 52:221–227. 2013. View Article : Google Scholar :
31	Ansari MJ, Ahmad S, Kohli K, Ali J and Khar RK: Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J Pharm Biomed Anal. 39:132–138. 2005. View Article : Google Scholar : PubMed/NCBI
32	Heger M, van Golen RF, Broekgaarden M and Michel MC: The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev. 66:222–307. 2013. View Article : Google Scholar : PubMed/NCBI
33	Tønnesen HH, de Vries H, Karlsen J and Beijersbergen van Henegouwen G: Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J Pharm Sci. 76:371–373. 1987. View Article : Google Scholar : PubMed/NCBI
34	Tønnesen HH, Karlsen J and van Henegouwen GB: Studies on curcumin and curcuminoids. VIII Photochemical stability of curcumin. Z Lebensm Unters Forsch. 183:116–122. 1986. View Article : Google Scholar
35	Galer P and Šket B: Photodegradation of methoxy substituted curcuminoids. Acta Chim Slov. 62:346–353. 2015. View Article : Google Scholar : PubMed/NCBI
36	Leite DP, Paolillo FR, Parmesano TN, Fontana CR and Bagnato VS: Effects of photodynamic therapy with blue light and curcumin as mouth rinse for oral disinfection: A randomized controlled trial. Photomed Laser Surg. 32:627–632. 2014. View Article : Google Scholar : PubMed/NCBI
37	Mahdi Z, Habiboallh G, Mahbobeh NN, Mina ZJ, Majid Z and Nooshin A: Lethal effect of blue light-activated hydrogen peroxide, curcumin and erythrosine as potential oral photosensitizers on the viability of Porphyromonas gingivalis and Fusobacterium nucleatum. Laser Ther. 24:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
38	Yin R and Hamblin MR: Antimicrobial photosensitizers: Drug discovery under the spotlight. Curr Med Chem. 22:2159–2185. 2015. View Article : Google Scholar : PubMed/NCBI
39	Skrzypczak-Jankun E, Zhou K, McCabe NP, Selman SH and Jankun J: Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med. 12:17–24. 2003.PubMed/NCBI
40	Jankun J, Doerks T, Aleem AM, Lysiak-Szydłowska W and Skrzypczak-Jankun E: Do human lipoxygenases have a PDZ regulatory domain? Curr Mol Med. 8:768–773. 2008. View Article : Google Scholar : PubMed/NCBI
41	Ji HF and Zhang HY: Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacol Sin. 29:143–151. 2008. View Article : Google Scholar : PubMed/NCBI
42	Zhang HY: One-compound-multiple-targets strategy to combat Alzheimer's disease. FEBS Lett. 579:5260–5264. 2005. View Article : Google Scholar : PubMed/NCBI
43	Barik A, Mishra B, Kunwar A, Kadam RM, Shen L, Dutta S, Padhye S, Satpati AK, Zhang HY and Indira Priyadarsini K: Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur J Med Chem. 42:431–439. 2007. View Article : Google Scholar : PubMed/NCBI
44	Barik A, Mishra B, Shen L, Mohan H, Kadam RM, Dutta S, Zhang HY and Priyadarsini KI: Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic Biol Med. 39:811–822. 2005. View Article : Google Scholar : PubMed/NCBI
45	Eybl V, Kotyzová D, Lesetický L, Bludovská M and Koutenský J: The influence of curcumin and manganese complex of curcumin on cadmium-induced oxidative damage and trace elements status in tissues of mice. J Appl Toxicol. 26:207–212. 2006. View Article : Google Scholar
46	Fouladvand M, Barazesh A and Tahmasebi R: Evaluation of in vitro antileishmanial activity of curcumin and its derivatives 'gallium curcumin, indium curcumin and diacethyle curcumin'. Eur Rev Med Pharmacol Sci. 17:3306–3308. 2013.
47	Gaurav C, Goutam R, Rohan KN, Sweta KT, Abhay CS and Amit GK: (Copper-curcumin) beta-cyclodextrin vaginal gel: delivering a novel metal-herbal approach for the development of topical contraception prophylaxis. Eur J Pharm Sci. 65:183–191. 2014. View Article : Google Scholar : PubMed/NCBI
48	Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI
49	John VD, Kuttan G and Krishnankutty K: Anti-tumour studies of metal chelates of synthetic curcuminoids. J Exp Clin Cancer Res. 21:219–224. 2002.PubMed/NCBI
50	Zebib B, Mouloungui Z and Noirot V: Stabilization of curcumin by complexation with divalent cations in glycerol/water system. Bioinorg Chem Appl. 2010:2927602010. View Article : Google Scholar :
51	Mei X, Xu D and Xu S, Zheng Y and Xu S: Gastroprotective and antidepressant effects of a new zinc(II)-curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Pharmacol Biochem Behav. 99:66–74. 2011. View Article : Google Scholar : PubMed/NCBI
52	Yu C, Mei XT, Zheng YP and Xu DH: Zn(II)-curcumin protects against hemorheological alterations, oxidative stress and liver injury in a rat model of acute alcoholism. Environ Toxicol Pharmacol. 37:729–737. 2014. View Article : Google Scholar : PubMed/NCBI
53	Refat MS: Synthesis and characterization of ligational behavior of curcumin drug towards some transition metal ions: Chelation effect on their thermal stability and biological activity. Spectrochim Acta A Mol Biomol Spectrosc. 105:326–337. 2013. View Article : Google Scholar : PubMed/NCBI
54	Barik A, Priyadarsini KI and Mohan H: Photophysical studies on binding of curcumin to bovine serum albumins. Photochem Photobiol. 77:597–603. 2003. View Article : Google Scholar : PubMed/NCBI
55	Wootton LL and Michelangeli F: The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase (SERCA) Ca²⁺ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors. J Biol Chem. 281:6970–6976. 2006. View Article : Google Scholar : PubMed/NCBI
56	Logan-Smith MJ, Lockyer PJ, East JM and Lee AG: Curcumin, a molecule that inhibits the Ca²⁺-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca²⁺. J Biol Chem. 276:46905–46911. 2001. View Article : Google Scholar : PubMed/NCBI
57	Hasmeda M and Polya GM: Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry. 42:599–605. 1996. View Article : Google Scholar : PubMed/NCBI
58	Jung KT and Lim KJ: Curcumin, COX-2, and Protein p300/CBP. Korean J Pain. 27:365–366. 2014. View Article : Google Scholar : PubMed/NCBI
59	Bukhari SN, Lauro G, Jantan I, Bifulco G and Amjad MW: Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines. Bioorg Med Chem. 22:4151–4161. 2014. View Article : Google Scholar : PubMed/NCBI
60	Skrzypczak-Jankun E, McCabe NP, Selman SH and Jankun J: Curcumin inhibits lipoxygenase by binding to its central cavity: Theoretical and X-ray evidence. Int J Mol Med. 6:521–526. 2000.PubMed/NCBI
61	Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ and Yang CS: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxy-genase. Carcinogenesis. 25:1671–1679. 2004. View Article : Google Scholar : PubMed/NCBI
62	Heng MC: Signaling pathways targeted by curcumin in acute and chronic injury: Burns and photo-damaged skin. Int J Dermatol. 52:531–543. 2013. View Article : Google Scholar
63	Reddy S and Aggarwal BB: Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341:19–22. 1994. View Article : Google Scholar : PubMed/NCBI
64	Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B and Puvanakrishnan R: Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol. 36:1967–1980. 2004. View Article : Google Scholar : PubMed/NCBI
65	Lin JK and Shih CA: Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis. 15:1717–1721. 1994. View Article : Google Scholar : PubMed/NCBI
66	Aggarwal BB, Surh J and Shishodia S: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer; New York, NY: 2007, View Article : Google Scholar
67	Asai A and Miyazawa T: Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 67:2785–2793. 2000. View Article : Google Scholar : PubMed/NCBI
68	Holder GM, Plummer JL and Ryan AJ: The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica; the fate of foreign compounds in biological systems. 8:761–768. 1978. View Article : Google Scholar
69	Wahlström B and Blennow G: A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 43:86–92. 1978. View Article : Google Scholar
70	Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: Problems and promises. Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
71	Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ and Berry DP: Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 90:1011–1015. 2004. View Article : Google Scholar : PubMed/NCBI
72	Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Lee CM, Ahn SC, Park YC and Park YM: Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol. 174:8116–8124. 2005. View Article : Google Scholar : PubMed/NCBI
73	Mun SH, Kim HS, Kim JW, Ko NY, Kim K, Lee BY, Kim B, Won HS, Shin HS, Han JW, et al: Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: Inhibition of the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci. 111:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
74	Kirkwood KL, Cirelli JA, Rogers JE and Giannobile WV: Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000. 43:294–315. 2007. View Article : Google Scholar : PubMed/NCBI
75	Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H and Vajaragupta O: Cytoprotective and cytotoxic effects of curcumin: Dual action on H2O2-induced oxidative cell damage in NG108-15 cells. Biol Pharm Bull. 26:725–728. 2003. View Article : Google Scholar : PubMed/NCBI
76	Guimarães MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL and Rossa C Jr: Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res. 46:269–279. 2011. View Article : Google Scholar : PubMed/NCBI
77	Jagetia GC and Rajanikant GK: Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg. 115:515–528. 2005. View Article : Google Scholar : PubMed/NCBI
78	Madhyastha R, Madhyastha H, Nakajima Y, Omura S and Maruyama M: Curcumin facilitates fibrinolysis and cellular migration during wound healing by modulating urokinase plasminogen activator expression. Pathophysiol Haemost Thromb. 37:59–66. 2010. View Article : Google Scholar : PubMed/NCBI
79	Oh S, Kyung TW and Choi HS: Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol Cells. 26:486–489. 2008.PubMed/NCBI
80	Singh R, Chandra R, Bose M and Luthra MP: Antibacterial activity of curcumin longa rhizome extract on periopathogenic bacteria. Curr Sci. 83:737–740. 2002.
81	Bhatia M, Urolagin SS, Pentyala KB, Urolagin SB, Menaka KB and Bhoi S: Novel therapeutic approach for the treatment of periodontitis by curcumin. J Clin Diagn Res. 8:ZC65–ZC69. 2014.
82	Gottumukkala SN, Koneru S, Mannem S and Mandalapu N: Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Contemp Clin Dent. 4:186–191. 2013. View Article : Google Scholar : PubMed/NCBI
83	Khafif A, Schantz SP, Chou TC, Edelstein D and Sacks PG: Quantitation of chemopreventive synergism between (−)-epigal-locatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 19:419–424. 1998. View Article : Google Scholar : PubMed/NCBI
84	Pari L and Murugan P: Tetrahydrocurcumin: Effect on chloroquine-mediated oxidative damage in rat kidney. Basic Clin Pharmacol Toxicol. 99:329–334. 2006. View Article : Google Scholar : PubMed/NCBI
85	Yodkeeree S, Garbisa S and Limtrakul P: Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol Sin. 29:853–860. 2008. View Article : Google Scholar : PubMed/NCBI
86	San Miguel SM, Opperman LA, Allen EP, Zielinski J and Svoboda KK: Bioactive antioxidant mixtures promote proliferation and migration on human oral fibroblasts. Arch Oral Biol. 56:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
87	Gu Y, Lee HM, Napolitano N, Clemens M, Zhang Y, Sorsa T, Zhang Y, Johnson F and Golub LM: 4-methoxycarbonyl curcumin: A unique inhibitor of both inflammatory mediators and periodontal inflammation. Mediators Inflamm. 2013:3297402013. View Article : Google Scholar
88	Elburki MS, Rossa C, Guimaraes MR, Goodenough M, Lee HM, Curylofo FA, Zhang Y, Johnson F and Golub LM: A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: Initial observations. Mediators Inflamm. 2014:9594712014. View Article : Google Scholar : PubMed/NCBI
89	Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:353–356. 1998. View Article : Google Scholar : PubMed/NCBI
90	Mazzarino L, Loch-Neckel G, Bubniak LS, Mazzucco S, Santos-Silva MC, Borsali R and Lemos-Senna E: Curcumin-loaded chitosan-coated nanoparticles as a new approach for the local treatment of oral cavity cancer. J Nanosci Nanotechnol. 15:781–791. 2015. View Article : Google Scholar : PubMed/NCBI
91	Gordon ON, Luis PB, Sintim HO and Schneider C: Unraveling curcumin degradation: Autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. J Biol Chem. 290:4817–4828. 2015. View Article : Google Scholar : PubMed/NCBI
92	Kaźmierkiewicz R, Czaplewski C and Ciarkowski J: Elucidation of neurophysin/bioligand interactions from molecular modeling. Acta Biochim Pol. 44:453–466. 1997.
93	Zhang YL, Tropsha A, McPhail AT and Lee KH: Antitumor agents. 152 In vitro inhibitory activity of etoposide derivative NPF against human tumor cell lines and a study of its conformation by X-ray crystallography, molecular modeling, and NMR spectroscopy. J Med Chem. 37:1460–1464. 1994. View Article : Google Scholar : PubMed/NCBI